HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 1141-1148.

AuthorsP Limonta, G Pratesi, R M Moretti, M Montagnani Marelli, M Motta, D Dondi
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 34 Issue 7 Pg. 1134-6 (Jun 1998) ISSN: 0959-8049 [Print] England
PMID9849469 (Publication Type: Comment, Letter)
Chemical References
  • Hormone Antagonists
  • Peptide Fragments
  • bombesin(6-14), Hca(6)-Leu(13)-psi(CH2N)-Tac(14)-
  • Gonadotropin-Releasing Hormone
  • cetrorelix
  • Bombesin
Topics
  • Bombesin (analogs & derivatives, pharmacology)
  • Gonadotropin-Releasing Hormone (analogs & derivatives, pharmacology)
  • Hormone Antagonists (pharmacology)
  • Humans
  • Male
  • Peptide Fragments (pharmacology)
  • Prostatic Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: